Searched for
PHARMACEUTICAL COMPANIES PROFIT
Donald Trump raised stakes in drug companies gaining from medicare exemptions, say DemocratsInvestments in pharmaceutical companies on behalf of Donald Trump saw a significant increase after returning to the White House. His portfo...- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsThe next few weeks are critical, and one should not be in a hurry to make market-related decisions. Better to be cautious – to wait and wat...
- HD Fire Protect IPO allotment likely today; GMP at 30%. Here's how to check statusHD Fire Protect IPO allotment status is expected today following a massive 131.70 times subscription. The Rs 712.31-crore public issue comm...
- Stocks in news: RIL, Wipro, Jio Financial, Tata Communications, YES Bank, PNBFrom a technical perspective, the 23,000–23,100 zone remains an immediate resistance level for the Nifty, according to Ponmudi R, CEO of En...
- Can Bonfiglioli Transmissions IPO deliver long-term growth for high-risk investors?Bonfiglioli Transmissions aims to raise Rs2,534 crore through an upcoming offer for sale. The promoter group's stake will reduce from 100% ...
- HD Fire Protect IPO Day 3: GMP at 33%, Day 2 subscription soars to 131 times; check key detailsHD Fire Protect's IPO has garnered significant interest, receiving bids significantly surpassing the available shares on offer. The grey ma...
- Long-term investing is about looking beyond narratives, including AI: 5 large-caps with an upside potential of up to 24%As we see a recovery in the market, it is good to be cognizant of the fact that more than the narratives on the street, it is the earnings ...
- Global Market: Japan’s Nikkei plunges nearly 5% as AI stocks tumble on CoreWeave debt concernsJapan’s Nikkei 225 plunged, while the broader Topix fell 2.5%, as AI-linked stocks led a broad selloff. Sentiment was hit by concerns over ...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhy should one be careful of the market at this juncture? One reason is that stocks are still not cheap. Even after all the nervousness of ...
- HD Fire Protect IPO Day 2: GMP signals 34% listing gain; key details insideThe HD Fire Protect IPO entered its second day of subscription with a grey market premium (GMP) of 34%, suggesting potential listing gains,...
- FM Sitharaman ready to hear out stock market tax debateFinance Minister Nirmala Sitharaman expressed interest in the discussions surrounding stock investment taxes and their implications. She me...
- HD Fire Protect IPO opens for subscription; GMP signals 30% listing gains, key details insideThe Rs 712.31-crore HD Fire Protect IPO is entirely an offer for sale (OFS) of 2.63 crore equity shares. As the issue comprises only an OFS...
- Panel to finalise cancer drugs for 30% trade margin cap; Rs 2,500 crore annual savings possibleAn expert group is finalizing the list of cancer medicines for a new trade margin cap. The government plans to implement a 30% cap to reduc...
- Jubilant Pharmova block deal: Quant Mutual Fund offloads Rs 190 crore stake amid Rs 800 crore fundraising plan; Abakkus buys 11 lakh sharesQuant Mutual Fund sold 20.81 lakh shares of Jubilant Pharmova worth Rs 190.47 crore in bulk deals, while Abakkus Four2Eight Opportunities F...
- 5 stocks with consistent score improvement and upside potential of up to 34% in 1 year, according to analystsGiven the current global and domestic situation, the chances are that the volatility quotient in the market will remain high. So, the best ...
- IPO calendar: After a week of lull, 5 companies to raise nearly Rs 1,600 crore this weekFive IPOs are scheduled to open for subscription next week, including mainboard issues from HD Fire Protect, Fusion CX and Sahajanand Medic...
- 5 stocks with consistent score improvement and upside potential of up to 30% in 1 year, according to analystsKeep a close watch on updates from FMCG companies, the cement sector, from real estate companies, especially about the commercial segment o...
- Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%The government is aiming to cap trade margins on anti-cancer medications at 30%. An expert committee has been tasked with compiling a repor...
- Nifty 50 companies likely to log strong double-digit growth in Q2Revenue and net profit of Nifty 50 companies are projected to grow by nearly 20% year-on-year. Analysts note that performance is driven by ...
- 5 stocks with consistent score improvement and upside potential of up to 32% in 1 year, according to analystsFor the next few weeks, the markets will readjust as business updates, which have started to arrive, and the Q2 earnings numbers roll in. C...
Load More
